Jade Biosciences Inc.

NASDAQ: JBIO · Real-Time Price · USD
7.33
0.56 (8.27%)
At close: Aug 15, 2025, 3:59 PM
7.30
-0.48%
After-hours: Aug 15, 2025, 07:20 PM EDT

Jade Biosciences Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-93.96K -75.52M -51.51M -22.96M
Depreciation & Amortization
n/a 96K 68K 15K
Stock-Based Compensation
2.51K n/a n/a n/a
Other Working Capital
18.44K 9.96M 6.39M -7.12M
Other Non-Cash Items
-71.12M 8.85M 4.57M 2.06M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
18.44K 9.8M 7.75M -6.51M
Operating Cash Flow
-71.2M -56.78M -39.12M -27.4M
Capital Expenditures
n/a -142K -195K -181K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-19.68M -123.98M -147.62M -113.25M
Sales Maturities Of Investments
75.71M 136M 154.74M n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
56.03M 11.88M 6.93M -113.43M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a
Financial Cash Flow
25.43M 46M 396K 190.46M
Net Cash Flow
10.26M 1.09M -31.8M 49.62M
Free Cash Flow
-45.23K -56.92M -39.32M -27.58M